These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38744720)

  • 1. On the utility of ultrafast MS1-only proteomics in drug target discovery studies based on thermal proteome profiling method.
    Fedorov II; Bubis JA; Kazakova EM; Lobas AA; Ivanov MV; Emekeeva DD; Tarasova IA; Nazarov AA; Gorshkov MV
    Anal Bioanal Chem; 2024 Jul; 416(18):4083-4089. PubMed ID: 38744720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Feasibility of Using an Ultra-Fast DirectMS1 Method of Proteome-Wide Analysis for Searching Drug Targets in Chemical Proteomics.
    Solovyeva EM; Bubis JA; Tarasova IA; Lobas AA; Ivanov MV; Nazarov AA; Shutkov IA; Gorshkov MV
    Biochemistry (Mosc); 2022 Nov; 87(11):1342-1353. PubMed ID: 36509723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DirectMS1Quant: Ultrafast Quantitative Proteomics with MS/MS-Free Mass Spectrometry.
    Ivanov MV; Bubis JA; Gorshkov V; Tarasova IA; Levitsky LI; Solovyeva EM; Lipatova AV; Kjeldsen F; Gorshkov MV
    Anal Chem; 2022 Sep; 94(38):13068-13075. PubMed ID: 36094425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting MS1-only Proteomics with Machine Learning Allows 2000 Protein Identifications in Single-Shot Human Proteome Analysis Using 5 min HPLC Gradient.
    Ivanov MV; Bubis JA; Gorshkov V; Abdrakhimov DA; Kjeldsen F; Gorshkov MV
    J Proteome Res; 2021 Apr; 20(4):1864-1873. PubMed ID: 33720732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DirectMS1: MS/MS-Free Identification of 1000 Proteins of Cellular Proteomes in 5 Minutes.
    Ivanov MV; Bubis JA; Gorshkov V; Tarasova IA; Levitsky LI; Lobas AA; Solovyeva EM; Pridatchenko ML; Kjeldsen F; Gorshkov MV
    Anal Chem; 2020 Mar; 92(6):4326-4333. PubMed ID: 32077687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target Engagement of Small Molecules: Thermal Profiling Approaches on Different Levels.
    Reckzeh ES; Brockmeyer A; Metz M; Waldmann H; Janning P
    Methods Mol Biol; 2019; 1888():73-98. PubMed ID: 30519941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products.
    Tu Y; Tan L; Tao H; Li Y; Liu H
    Phytomedicine; 2023 Jul; 116():154862. PubMed ID: 37216761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in high-throughput proteomic analysis].
    Wu Q; Sui X; Tian R
    Se Pu; 2021 Feb; 39(2):112-117. PubMed ID: 34227342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal Proteome Profiling for Drug Target Identification and Probing of Protein States.
    Sauer P; Bantscheff M
    Methods Mol Biol; 2023; 2718():73-98. PubMed ID: 37665455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MetaProClust-MS1: an MS1 Profiling Approach for Large-Scale Microbiome Screening.
    Simopoulos CMA; Ning Z; Li L; Khamis MM; Zhang X; Lavallée-Adam M; Figeys D
    mSystems; 2022 Aug; 7(4):e0038122. PubMed ID: 35950762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tandem mass tag-based thermal proteome profiling for the discovery of drug-protein interactions in cancer cells.
    Johnson FD; Hughes CS; Liu A; Lockwood WW; Morin GB
    STAR Protoc; 2023 Mar; 4(1):102012. PubMed ID: 36856765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass Spectrometry-Based Chemical Proteomics for Drug Target Discoveries.
    Fedorov II; Lineva VI; Tarasova IA; Gorshkov MV
    Biochemistry (Mosc); 2022 Sep; 87(9):983-994. PubMed ID: 36180990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome Profiling.
    George AL; Sidgwick FR; Watt JE; Martin MP; Trost M; Marín-Rubio JL; Dueñas ME
    J Proteome Res; 2023 Aug; 22(8):2629-2640. PubMed ID: 37439223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome Integral Solubility Alteration (PISA) Assay in Mammalian Cells for Deep, High-Confidence, and High-Throughput Target Deconvolution.
    Zhang X; Lytovchenko O; Lundström SL; Zubarev RA; Gaetani M
    Bio Protoc; 2022 Nov; 12(22):. PubMed ID: 36532690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Proteomics-Based Drug Mechanism-of-Action Studies Using 16-Plex Isobaric Mass Tags.
    Zinn N; Werner T; Doce C; Mathieson T; Boecker C; Sweetman G; Fufezan C; Bantscheff M
    J Proteome Res; 2021 Mar; 20(3):1792-1801. PubMed ID: 33621079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Profiling of Proteome and Phosphoproteome by Isobaric Labeling, Extensive Liquid Chromatography, and Mass Spectrometry.
    Bai B; Tan H; Pagala VR; High AA; Ichhaporia VP; Hendershot L; Peng J
    Methods Enzymol; 2017; 585():377-395. PubMed ID: 28109439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isobaric Labeling-Based LC-MS/MS Strategy for Comprehensive Profiling of Human Pancreatic Tissue Proteome.
    Liu CW; Zhang Q
    Methods Mol Biol; 2018; 1788():215-224. PubMed ID: 28986817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass Spectrometry-Based Proteomics for Biomarker Discovery.
    Cao Z; Yu LR
    Methods Mol Biol; 2022; 2486():3-17. PubMed ID: 35437715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS.
    Bian Y; Zheng R; Bayer FP; Wong C; Chang YC; Meng C; Zolg DP; Reinecke M; Zecha J; Wiechmann S; Heinzlmeir S; Scherr J; Hemmer B; Baynham M; Gingras AC; Boychenko O; Kuster B
    Nat Commun; 2020 Jan; 11(1):157. PubMed ID: 31919466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the carrier proteome limit for single-cell proteomics.
    Cheung TK; Lee CY; Bayer FP; McCoy A; Kuster B; Rose CM
    Nat Methods; 2021 Jan; 18(1):76-83. PubMed ID: 33288958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.